Skip to content

Alphatec Holdings ATEC Free cash flow

Free cash flow at other companies

Johnson & Johnson logo
Johnson & JohnsonJNJ
$1.47B-56.6%
Stryker logo
StrykerSYK
$415M+227%
Medtronic logo
MedtronicMDT
$2.09B+0.8%
IAR
Integra LifeSciencesIART
-$5.05M+87.4%
Enovis logo
EnovisENOV
-$28.85M+35.7%
Globus Medical logo
Globus MedicalGMED

Other financials

Income statement

See full
Revenue$192.1M+13.6%
Gross profit$136.5M+17.7%
Operating income-$22.6M+49.0%
Net income-$33.9M+34.7%
EPS (diluted)-$0.22+37.1%

Balance sheet

See full
Cash & equivalents$139.9M-8.7%
Total debt$603.1M+3.7%
Total equity-$5.3M+93.8%
Total assets$799.5M+1.8%

Cash flow

See full
Operating cash flow$1.3M+126%
CapEx$12.1M+21.7%

Valuation

See full
Market cap$1.34B+12.7%
Enterprise value$1.8B+11.7%
P/S1.7×-0.1×

Profitability

See full
Gross margin70.2%+1.2pp
Operating margin-7.7%-3.0pp
Net margin-15.9%-4.4pp
FCF margin-12.7%-5.1pp

Returns & leverage

See full
Return on equity-812.1%
Debt / equity48×
Current ratio1.9×-0.9×

Where this comes from

Calculated from Alphatec Holdings’s reported figures.

The official record: Alphatec Holdings’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Alphatec Holdings's free cash flow.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Alphatec Holdings's free cash flow?
Alphatec Holdings (ATEC) reported free cash flow of -$10.8M in Q1 2026.
How has Alphatec Holdings's free cash flow changed year-over-year?
Alphatec Holdings's free cash flow increased by 27.9% year-over-year, from -$14.97M to -$10.8M.
What is the long-term trend for Alphatec Holdings's free cash flow?
Over 3 years (2021 to 2024), Alphatec Holdings's free cash flow has grown at a -1.3% compound annual growth rate (CAGR), from -$141.86M to -$136.42M.
What does free cash flow mean?
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and maintain or expand its capital asset base. It serves as a critical indicator of a company's ability to fund organic growth, pay down debt, or return capital to shareholders without relying on external financing.